Speech-Language Pathologists in Brownfield, TX Accepting Medicare

3 Speech-Language Pathologists found. Showing 1 - 3

Courtney Noel Clay, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1101 E Lake St, Brownfield, TX 79316 Phone: 806-637-7561

Jaci Zingerman, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 601 E Tahoka Rd, Brownfield, TX 79316 Phone: 806-637-6455

Melissa Salas, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 E Cactus Ln, Brownfield, TX 79316 Phone: 806-891-8971

News Archive

Study shows importance of disclosing physician conflicts of interest in MS ISCTs to potential participants

If you're one of the nearly half a million Americans living with multiple sclerosis (MS) - a slowly disabling disease of the central nervous system - you are likely dependent on disease-modifying drugs to prevent symptoms such as vision problems, balance issues and weakness. Often, these treatments have been developed through pharmaceutical industry-sponsored clinical trials (ISCT) in collaboration with academic or private practice physicians who care for MS patients.

Dopamine and Parkinson's

Parkinson's disease and drug addiction are polar opposite diseases, but both depend upon dopamine in the brain. Parkinson's patients don't have enough of it; drug addicts get too much of it. Although the importance of dopamine in these disorders has been well known, the way it works has been a mystery.

Dopamine therapy can boost creativity in patients with Parkinson's

Some Parkinson's Disease patients can suddenly become creative when they take dopamine therapy, producing pictures, sculptures, novels and poetry. But their new-found interests can become so overwhelming that they ignore other aspects of their everyday life, such as daily chores and social activities, according to research published in the March issue of the European Journal of Neurology.

Direct medical costs projected to increase to $49 billion annually by 2020

The American College of Chest Physicians announced today the Online First publication of 'Total and State-Specific Medical and Absenteeism Costs of Chronic Obstructive Pulmonary Disease Among Adults Aged ≥18 Years in the United States for 2010 and Projections Through 2020' in the journal CHEST.

SK Biopharmaceuticals initiates YKP10811 phase 2 trial in chronic constipation

SK Biopharmaceuticals, a South Korean pharmaceutical company, announced today that the first patient was dosed in a phase 2 clinical trial in the US for patients suffering with chronic constipation using their new chemical entity YKP10811.

Read more Medical News

› Verified 6 days ago